Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Promising data presented from phase II Cinryze combination trial

March 14, 2012

Further data reported on add-on boceprevir therapy in HCV/HIV-coinfected patients

March 13, 2012

In vitro results show potency of novel bispecific HIV-1-neutralizing antibody

March 13, 2012

Dendritic cell-based vaccine is safe in patients with HIV

March 12, 2012

Recombinant protein therapy active against HIV in phase II trial

March 9, 2012

Gene-modified stem cell therapy shows promise to combat HIV infection

March 9, 2012

Canadian study assesses involvement of neuroinflammation in healthy aging humans

March 9, 2012

HCV NS3 resistance variants detected after 7-day MK-5172 course

March 8, 2012

Fatty acid blocks HIV-1 infection in ex vivo cervical tissue model

March 8, 2012

Novel SYK inhibitor shows potential as asthma therapeutic

March 7, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...